Filterable News List

Tokyo, Japan. Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT), a developer, manufacturer, and seller of stem-cell-based and regenerative-medicine-related cosmetics and health products, announced its unaudited financial results for the six months ended May 31, 2026.During the first half of fiscal 2026, the company successfully returned to profitability and expanded its revenue in yen terms,…

… Read on — Pro Members

Mexico City, Mexico - Grupo Aeromexico, S.A.B. de C.V. (BMV & NYSE: AERO) announced that the US Department of Transportation (DOT) has revoked, effective immediately, its October 28, 2025 order that had previously disapproved certain existing, proposed, and prospective schedules by Mexican air carriers between Mexico and the United States.

The revocation allows Aeromexico to add frequencies and introduce new scheduled services between Mexico City International Airport or Felipe Angeles International Airport and the United States, subject to applicable regulatory requirements. The DOT determined that actions taken by the Government of Mexico successfully addressed the concerns of the prior order.

Key Highlights

• US DOT revokes restrictions affecting Mexico-US airline services effective immediately.
• Aeromexico gains flexibility to expand frequencies and introduce new transborder routes.
• Changes apply to operations from Mexico City International Airport and Felipe Angeles International Airport.

Palo Alto, California TCGX Acquisition Corp. II announced the pricing of its initial public offering of 10,000,000 Class A ordinary shares at a price of $10.00 per share. The offering generated gross proceeds of $100,000,000.The company confirmed that unlike certain other special purpose acquisition company offerings, investors in this transaction will not receive warrants that…

… Read on — Pro Members

NEWTOWN SQUARE, PA, USA - ArriVent BioPharma, Inc. (Nasdaq: AVBP) announced the publication of FURTHER Phase 1b results of firmonertinib in Cancer Cell, highlighting preclinical and clinical findings supporting its potential as the first oral, chemotherapy-free targeted therapy for treatment-naive patients with advanced EGFR PACC-mutant non-small cell lung cancer (NSCLC).

EGFR PACC-mutant NSCLC represents approximately 12 percent of EGFR-mutant tumors and currently lacks an established targeted standard of care. The publication demonstrates that firmonertinib's unique molecular structure fits EGFR PACC mutations well, offering potential high anti-tumor activity and robust clinical responses in this underserved patient population.

Key Highlights

• Enhanced in vitro potency vs. osimertinib: Firmonertinib's unique trifluoroethoxy side chain creates additional contact points for binding to PACC-mutated EGFR's kinase domain.
• Robust, durable clinical activity: 43 percent and 68 percent confirmed overall response rate (ORR), with 11.1- and 16.0-months median progression free survival, respectively.
• Meaningful intracranial activity: 47 percent confirmed intracranial ORR among patients with baseline brain metastases.
• ctDNA clearance: Correlated strongly with complete molecular response, higher ORR, and longer median progression-free survival.

KELLOGG, Idaho, USA -- Sunshine Silver Mining & Refining Company (NYSE: SSMR) provided an operational readiness update for the Sunshine Mine in Idaho's Silver Valley, focusing on underground development, infrastructure modernization, and surface site preparation ahead of a planned return to production in late 2028.

The company is advancing its feasibility study, targeted for completion in the second quarter of 2027. Recent milestones include significant underground development meters, infill drilling progress, and infrastructure upgrades such as the new production hoist servicing the Jewell Shaft.

Key Highlights

• Advancement of underground development, rehabilitation, and drilling activities.
• Completion of the new production hoist servicing the Jewell Shaft.
• Initiation of the Silver Summit Hoist and Shaft upgrade project.
• Demolition of the legacy mill and related surface infrastructure.

Centennial, Colorado, USA - NioCorp Developments Ltd. (NASDAQ:NB) has announced its preliminary unaudited financial results for the three-month period ended September 30, 2026. The company reported a net income attributable to NioCorp of $3.7 million, or $0.03 per share (basic), compared to a net loss of $42.7 million, or $0.53 per share (basic), for the same period in 2025. As of September 30, 2026, the company held a cash balance of $405.1 million.

The net income for the quarter was primarily driven by non-cash gains of approximately $8.5 million related to earnout shares and warrants classified as liabilities, resulting from a decrease in the company's common share closing price between June 30 and September 30, 2026. Operating cash outflows for the quarter totaled $6.1 million, while investing outflows reached $5.9 million, largely dedicated to ongoing construction of the mine portal at the Elk Creek Critical Minerals Project.

Financial Highlights

• Net income of $3.7 million ($0.03 per share) for Q3 2026.
• Cash balance of $405.1 million as of September 30, 2026.
• Non-cash gains of approximately $8.5 million from liability-classified instruments.
• Operating cash outflows of $6.1 million and investing outflows of $5.9 million.

TOKYO and NEW YORK, Oct. 16, 2026 - Advasa Holdings, Inc. (Nasdaq: ADBT), a fintech payment holding company providing Earned Wage Access and financial infrastructure solutions, announced that its Board of Directors has adopted a new dividend policy. Beginning with the fiscal year ending March 31, 2027, the company targets an annual cash dividend payout…

… Read on — Pro Members

DUBAI, UAE, October 16, 2026 -- Robo.ai Inc. (Nasdaq: AIIO), a UAE-based and U.S.-listed technology group, announced that it will implement a 1-for-25 reverse stock split of its ordinary shares, subject to shareholder approval at an upcoming extraordinary general meeting (EGM). The reverse stock split will affect both Class A and publicly traded Class B ordinary shares, becoming effective at 9:30 am U.S. Eastern time on November 6, 2026. Following the split, the Class B ordinary shares will continue trading on Nasdaq under the existing ticker symbol AIIO with a new CUSIP number.

Transaction Details

• Ratio: 1-for-25 reverse stock split
• Effective Date: November 6, 2026
• Class A Shares: Reduced from 13,817,501 to 552,701 issued and outstanding shares
• Class B Shares: Reduced from 222,116,290 to 8,884,684 issued and outstanding shares
• New CUSIP: G6693P130

The extraordinary general meeting is scheduled for October 26, 2026, in Dubai, United Arab Emirates, where shareholders will vote on the proposed reverse stock split, authorized share capital adjustments, and the adoption of the seventh amended and restated memorandum and articles of association. Shareholders of record as of October 14, 2026, are entitled to vote at the meeting.

Hong Kong, Oct. 16, 2026 - Etoiles Capital Group Co., Ltd. (Nasdaq: EFTY), a company specializing in integrated investor relations services in Hong Kong, today announced the successful completion of its domestication process. The company has officially changed its jurisdiction of incorporation from the Cayman Islands to the State of Nevada, USA.

The domestication was approved by the company's shareholders at its annual general meeting held on October 15, 2026. The change became effective on October 19, 2026. As a result, each Class A ordinary share issued and outstanding will be automatically converted into one share of common stock of the continuing entity following the domestication.

Key Details of the Domestication

• Shareholder Approval: The domestication received approval from shareholders on October 15, 2026.

• Effective Date: The change of jurisdiction became effective on October 19, 2026.

• Share Conversion: All existing Class A ordinary shares will convert into common stock of the Nevada entity on a one-for-one basis.

• Trading Status: Trading in the company's Class A Ordinary Shares has been suspended since October 6, 2025, and remains suspended. The company's Common Stock is expected to commence trading on the Nasdaq under the symbol "EFTY" once trading resumes.

• Shareholder Action: No action is required from existing shareholders regarding this domestication.

• CUSIP Number: The company's CUSIP number will be changed to 29771T102.

• Business Operations: Etoiles Capital Group does not anticipate any impact on its day-to-day business operations as a result of the domestication.

Further details regarding this corporate action will be provided in a Current Report on Form 8-K to be filed with the U.S. Securities and Exchange Commission (SEC).

NEW YORK, October 15, 2026 - Pine Tree Acquisition Corp. (Nasdaq: PAXGU) announced the completion of the sale of an additional 600,000 units pursuant to the partial exercise of the over-allotment option granted to Maxim Group LLC in connection with its initial public offering.The units were sold at a price of $10.00 per unit, generating…

… Read on — Pro Members